Home
/
Alignment Healthcare, Inc.
/
Financials
/
Quarterly
Alignment Healthcare, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Alignment Healthcare, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$993.70M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$1.02B
Jul 30, 2025
Q1
2025
Mar 31, 2025
$926.93M
May 1, 2025
Q3
2025
Sep 30, 2024
$692.43M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$681.29M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$628.60M
May 1, 2025
Q3
2024
Sep 30, 2023
$456.71M
Oct 29, 2024
Q2
2024
Jun 30, 2023
$462.38M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$439.16M
May 2, 2024
Q3
2023
Sep 30, 2022
$360.35M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$366.47M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$345.53M
May 4, 2023
Q3
2022
Sep 30, 2021
$293.47M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$308.95M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$267.08M
May 5, 2022
Q3
2021
Sep 30, 2020
$247.87M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$244.31M
Aug 9, 2021
Q1
2021
Mar 31, 2020
$224.63M
May 17, 2021
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
$450.24M
Nov 2, 2023
Q2
2023
Jun 30, 2023
$456.88M
Aug 3, 2023
Q1
2023
Mar 31, 2023
$434.81M
May 4, 2023
Q3
2023
Sep 30, 2022
$359.98M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$366.18M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$345.29M
May 4, 2023
Q3
2022
Sep 30, 2021
$293.28M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$308.74M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$267.00M
May 5, 2022
Q3
2021
Sep 30, 2020
$245.49M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$243.96M
Aug 9, 2021
Q1
2021
Mar 31, 2020
$224.27M
May 17, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.73M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$15.67M
Jul 30, 2025
Q1
2025
Mar 31, 2025
($9.11M)
May 1, 2025
Q3
2025
Sep 30, 2024
($26.41M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($24.01M)
Jul 30, 2025
Q1
2025
Mar 31, 2024
($46.52M)
May 1, 2025
Q3
2024
Sep 30, 2023
($35.05M)
Oct 29, 2024
Q2
2024
Jun 30, 2023
($28.48M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($37.28M)
May 2, 2024
Q3
2023
Sep 30, 2022
($40.25M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($11.58M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($40.82M)
May 4, 2023
Q3
2022
Sep 30, 2021
($45.82M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($44.76M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($56.87M)
May 5, 2022
Q3
2021
Sep 30, 2020
$10.85M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$8.37M
Aug 9, 2021
Q1
2021
Mar 31, 2020
($10.07M)
May 17, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$7.68M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$22.75M
Jul 30, 2025
Q1
2025
Mar 31, 2025
($5.39M)
May 1, 2025
Q3
2025
Sep 30, 2024
($19.52M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($18.38M)
Jul 30, 2025
Q1
2025
Mar 31, 2024
($41.11M)
May 1, 2025
Q3
2024
Sep 30, 2023
($29.76M)
Oct 29, 2024
Q2
2024
Jun 30, 2023
($23.66M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($32.49M)
May 2, 2024
Q3
2023
Sep 30, 2022
($33.41M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($6.65M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($36.48M)
May 4, 2023
Q3
2022
Sep 30, 2021
($41.45M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($40.49M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($52.66M)
May 5, 2022
Q3
2021
Sep 30, 2020
$15.06M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$12.59M
Aug 9, 2021
Q1
2021
Mar 31, 2020
($5.12M)
May 17, 2021